Peter S Dragovich

15PUBLICATIONS
22CO-AUTHORS
Molecular targetsCharacterisation of biological macromoleculesPharmaceutical delivery technologiesGene and molecular therapyGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 18, 2026
Antibody-Mediated Delivery of BRM/BRG1 Protein Degraders Affords Strong Antitumor Efficacy in Multiple BRM-Dependent Non-Small Cell Lung Cancer Xenograft Models.

|Aug 08, 2025
Property-Based Prediction Uncovers Intestinal Excretion as an Elimination Route of Small-Molecule Drugs.

Chen Chen, Weiping Zhao, Lin Cao

|Jul 25, 2025
Elucidating Molecular Mechanisms of Drug-Induced Hepatotoxicity of Lapatinib.

Qinying Yu, Li Ma, Leah M Norona

|Jan 05, 2024
PROTACs Targeting BRM (SMARCA2) Afford Selective In Vivo Degradation over BRG1 (SMARCA4) and Are Active in BRG1 Mutant Xenograft Tumor Models.

Michael Berlin, Jennifer Cantley, Mark Bookbinder

|May 04, 2022
Degrader-antibody conjugates.

Peter S Dragovich

|Mar 14, 2022
Antibody-Drug Conjugates for Immunology.

Peter S Dragovich

Pageof 3

Frequent Collaborators

3 joint publications

Christopher M Rose

3 joint publications

Huifen Chen

2 joint publications

Donglu Zhang

2 joint publications

Stefan G Koenig